Inotiv, Inc. Files 8-K on Financials
Ticker: NOTV · Form: 8-K · Filed: Feb 5, 2025 · CIK: 720154
| Field | Detail |
|---|---|
| Company | Inotiv, INC. (NOTV) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Inotiv dropped an 8-K detailing financials - check it out.
AI Summary
Inotiv, Inc. filed an 8-K on February 5, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company, formerly known as BIOANALYTICAL SYSTEMS INC, is incorporated in Indiana and headquartered in West Lafayette.
Why It Matters
This 8-K filing provides investors with crucial updates on Inotiv, Inc.'s financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Inotiv, Inc. (company) — Registrant
- BIOANALYTICAL SYSTEMS INC (company) — Former company name
- February 5, 2025 (date) — Date of report
- 2701 KENT AVENUE (address) — Principal executive offices
- WEST LAFAYETTE, INDIANA (location) — Principal executive offices location
FAQ
What is the primary purpose of this 8-K filing for Inotiv, Inc.?
The primary purpose is to report on Inotiv, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on February 5, 2025.
What was Inotiv, Inc.'s former company name?
Inotiv, Inc.'s former company name was BIOANALYTICAL SYSTEMS INC.
Where are Inotiv, Inc.'s principal executive offices located?
Inotiv, Inc.'s principal executive offices are located at 2701 Kent Avenue, West Lafayette, Indiana.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 522 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-02-05 16:17:21
Filing Documents
- notv-20250205.htm (8-K) — 27KB
- notv-20240205xex991.htm (EX-99.1) — 246KB
- 0001628280-25-004043.txt ( ) — 412KB
- notv-20250205.xsd (EX-101.SCH) — 2KB
- notv-20250205_lab.xml (EX-101.LAB) — 21KB
- notv-20250205_pre.xml (EX-101.PRE) — 12KB
- notv-20250205_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 5, 2025 , Inotiv, Inc. issued a press release announcing financial results for the three months ended December 31, 2024. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Inotiv, Inc. press release, issued February 5, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOTIV, INC. Date: February 5, 2025 By: /s/ Beth A. Taylor Chief Financial Officer, Senior Vice President—Finance